Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +335.75%
#4 aPriori aPriori +131.95%
#5 Bedrock Bedrock +76.08%
#6 Cysic Cysic +50.91%
#7 Prom Prom +45.70%
#8 Playnance Playnance +35.00%
#9 Bitway Bitway +27.78%
#10 COTI COTI +27.04%
Coin of the day
Wrapped One Wrapped One
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Peringkat dalam Saham #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Harga Saham
$0.00023723
Terakhir disinkronkan: 2024-08-26
Kapitalisasi Pasar
$1.41K
Perubahan (1 hari)
111.67%
Perubahan (1 tahun)
0.00%
Negara
FR
Perdagangan Pharnext S.A. (ALPHA)

Kategori

Healthcare
Pendapatan untuk Pharnext S.A. (ALPHA)
Pendapatan pada Dec 2023 TTM: $-487.61K
Menurut laporan keuangan terbaru dari Pharnext S.A., pendapatan saat ini (TTM) adalah $-487.61K. Pada tahun 2022, perusahaan menghasilkan pendapatan sebesar $598.55 penurunan dibandingkan dengan pendapatan pada tahun 2021 yang sebesar $96.41K. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan Pharnext S.A. dari 2013 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Mengubah
2026 (TTM) $-487.61K -4,510.88%
2023 $11.05K 1,746.90%
2022 $598.55 -99.38%
2021 $96.41K 98.76%
2020 $48.51K -82.90%
2019 $283.61K -96.39%
2018 $7.85M 96.92%
2017 $3.99M -14.33%
2016 $4.65M 62.80%
2015 $2.86M -14.35%
2014 $3.34M -7.92%
2013 $3.62M 0.00%
Pendapatan untuk perusahaan serupa atau pesaing
Perusahaan Pendapatan Perbedaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -2,589,130.69%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -1,234,964.32%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -2,073,651.57%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR